MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
552.57%
Quick Ratio
552.57%
Debt to Asset Ratio
51.88%
Unit: Thousand (K) dollars
Assets Breakdown
Cash, cash equivalents, and rest...
Supplies
Accounts receivable
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Long-term indebtedness, net of d...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash, cash equivalents, and restricted cash
690,915
821,147
797,799
754,739
Short-term marketable securities
102,200
2,315
2,295
2,272
Accounts receivable
116,888
90,517
112,140
26,697
Supplies
123,791
76,289
63,625
49,303
Prepaid expenses and other current assets
24,034
23,912
21,941
21,234
Total current assets
1,057,828
1,014,180
997,800
854,245
Property and equipment, net
95,716
82,669
63,170
63,997
Goodwill
19,344
19,344
19,344
19,344
Other assets
56,732
46,195
45,349
46,985
Total assets
1,229,620
1,162,388
1,125,663
984,571
Accounts payable
85,986
69,802
39,206
28,999
Accrued expenses and other current liabilities
105,273
73,921
87,770
56,867
Current portion of indebtedness
178
173
169
164
Total current liabilities
191,437
143,896
127,145
86,030
Long-term indebtedness, net of debt discounts
392,973
381,402
378,823
376,296
Warrant liabilities
-
-
0
0
Other long-term liabilities
53,476
43,600
42,388
43,881
Total liabilities
637,886
568,898
548,356
506,207
Redeemable convertible preferred stock-Series APreferred Stock
-
-
0
0
Redeemable convertible preferred stock-Series BPreferred Stock
-
-
0
0
Redeemable convertible preferred stock-Series CPreferred Stock
-
-
0
0
Redeemable convertible preferred stock-Series DPreferred Stock
-
-
0
0
Redeemable convertible preferred stock
-
-
0
0
Preferred stock
0
0
0
-
Common stock
283
284
283
283
Treasury stock
0
16,896
16,896
16,917
Additional paid-in capital
3,140,805
3,158,455
3,141,720
3,124,943
Related party promissory note receivable (see note 7)
-
-
0
0
Accumulated deficit
-2,549,883
-2,549,246
-2,548,736
-2,630,693
Accumulated other comprehensive income
529
893
936
748
Total shareholders' equity
591,734
593,490
577,307
478,364
Total liabilities and shareholders' equity
1,229,620
1,162,388
1,125,663
984,571
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash, cash
equivalents, and restricted...
$690,915K
(-4.10%↓ Y/Y)
Supplies
$123,791K
(204.81%↑ Y/Y)
Accounts receivable
$116,888K
(129.69%↑ Y/Y)
Short-term marketable
securities
$102,200K
(4444.24%↑ Y/Y)
Prepaid expenses and
other current assets
$24,034K
(25.67%↑ Y/Y)
Total current assets
$1,057,828K
(26.94%↑ Y/Y)
Property and equipment,
net
$95,716K
(56.11%↑ Y/Y)
Other assets
$56,732K
(38.10%↑ Y/Y)
Goodwill
$19,344K
(0.00%↑ Y/Y)
Total assets
$1,229,620K
(28.75%↑ Y/Y)
Total liabilities and
shareholders' equity
$1,229,620K
(28.75%↑ Y/Y)
Total liabilities
$637,886K
(27.03%↑ Y/Y)
Total shareholders'
equity
$591,734K
(30.65%↑ Y/Y)
Accumulated deficit
-$2,549,883K
(3.96%↑ Y/Y)
Long-term indebtedness,
net of debt...
$392,973K
(5.18%↑ Y/Y)
Total current
liabilities
$191,437K
(112.28%↑ Y/Y)
Other long-term
liabilities
$53,476K
(39.39%↑ Y/Y)
Additional paid-in capital
$3,140,805K
(0.54%↑ Y/Y)
Accumulated other
comprehensive income
$529K
(-20.93%↓ Y/Y)
Common stock
$283K
(0.35%↑ Y/Y)
Accrued expenses and
other current...
$105,273K
(71.57%↑ Y/Y)
Accounts payable
$85,986K
(199.31%↑ Y/Y)
Current portion of
indebtedness
$178K
(87.37%↑ Y/Y)
Buy us a coffee
TN0277-v12_How-To-Order-1(1)
Caris Life Sciences, Inc. (CAI)
TN0277-v12_How-To-Order-1(1)
Caris Life Sciences, Inc. (CAI)